-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Lucid Diagnostics Inc. annual Deferred Federal Income Tax Expense (Benefit) history and growth rate from 2020 to 2023.
- Lucid Diagnostics Inc. annual Deferred Federal Income Tax Expense (Benefit) for 2023 was -$9.28M, a 26.9% increase from 2022.
- Lucid Diagnostics Inc. annual Deferred Federal Income Tax Expense (Benefit) for 2022 was -$12.7M, a 161% decline from 2021.
- Lucid Diagnostics Inc. annual Deferred Federal Income Tax Expense (Benefit) for 2021 was -$4.86M, a 236% decline from 2020.
Deferred Federal Income Tax Expense (Benefit), Annual (USD)
Deferred Federal Income Tax Expense (Benefit), YoY Annual Growth (%)